The FDAs Pharmacy Compounding Advisory Committee will review whether to officially clear any of them for compounding under 503A at its July 23-24, 2026 meeting
[DOI] [PMC free article] [PubMed] [Google Scholar] 250.Spanou C., Veskoukis A.S., Kerasioti T., Kontou M., Angelis A., Aligiannis N., Skaltsounis A.L., Kouretas D
Tirzepatide may be the better choice if: Maximum weight loss is the priority clinical data consistently shows superior outcomes at every benchmark You have a higher starting BMI (35+) the absolute weight loss advantage is most meaningful at higher baseline weights You have insulin resistance, prediabetes, or metabolic syndrome tirzepatides dual GIP/GLP-1 mechanism offers stronger glycemic and metabolic improvements than semaglutide alone, making it particularly effective tirzepatide for insulin resistance cases You plateaued or under-responded to semaglutide tirzepatide frequently produces results where semaglutide stalled Insurance covers Zepbound or Mounjaro when covered, the cost gap narrows significantly Learn more about our tirzepatide weight loss program and whether you qualify
Indeed, up to 90% of H
First, it hits GLP-1 receptors, the same ones targeted by semaglutide and tirzepatide, helping regulate appetite and food intake
Our weight loss clinic provides ongoing support to help patients maintain these long-term benefits
